Publications

• Priest, C., Nagari, R.T., Bideyan, L., Lee, S.D., Nguyen, A., Xiao, X., and Tontonoz, P. (2022). Brap regulates liver morphology and hepatocyte turnover via modulation of the Hippo pathway. Proc Natl Acad Sci USA. doi: 10.1073/pnas.2201859119. (PMID35476518)
• Bideyan, L., Fan, W., Kaczor Urbanowicz, K., Priest, C., Casero, D. and Tontonoz, P. (2022). Integrative analysis reveals multiple modes of LXR transcriptional regulation in liver. Proc Natl Acad Sci USA. doi 10.1073/pnas.2122683119. (PMID 35145035)
• Xiao, X., Kim, Y., Romartinez-Alonso, B., Sirvydis, K., Ory, D.S., Schwabe, J.W.R., Jung, M.E. and Tontonoz, P. (2021). Selective Aster inhibitors distinguish vesicular and nonvesicular sterol transport mechanisms. Proc Natl Acad Sci U S A. doi: 10.1073/pnas.2024149118. (PMID 33376205)
• Bideyan, L., Nagari, R., Tontonoz, P. (2021). Hepatic transcriptional responses to fasting and feeding. Genes Dev. 35:635-657. doi: 10.1101/gad.348340.121. (PMID: 33888557)
•  Ferrari, A., He, C., Kennelly, J.P., Sandhu, J., Xiao, X., Chi, X., Jiang, H., Young, S.G. and Tontonoz, P. (2020). Aster proteins regulate the accessible cholesterol pool in the plasma membrane. Mol. Cell. Biol. 40:e00255-20. doi:10.1128/MCB.00255-20. (PMID 32719109).
• Zhou, Q.D., Chi, X., Lee, M.S., Hsieh, W.Y., Mkrtchyan, J.J., Feng, A-C., He, C., York, A.G., Bui, V.L., Kronenberger, E.B., Ferrari, A., Xiao, X., Daly, A.E., Tarling, E.J., Damoiseaux, R., Scumpia, P.O., Smale, S.T., Williams, K.J., Tontonoz, P. and Bensinger, S. J. (2020). Interferon-mediated reprogramming of plasma membrane cholesterol to evade bacterial toxins. Nature Immunology. 21:746-755. doi: 10.1038/s41590-020-0695-4. (PMID 32514064)
•  Ichu, T.A., Reed, A., Ogasawara, D., Ulanovskaya, O., Roberts, A., Aguirre, C.A., Bar-Peled, L., Gao, J., Germain, J., Barbas, S., Masuda, K., Conti, B., Tontonoz, P., Cravatt, B.F. (2020). ABHD12 and LPCAT3 Interplay Regulates a Lyso-phosphatidylserine-C20:4 Phosphatidylserine Lipid Network Implicated in Neurological Disease. Biochemistry. doi:10.1021/acs.biochem. 0c00292. (PMID 32364701)
• Gao, J., Littman, R., Diamante, G., Xiao, X., Ahn, I., Yang, X., Cole, T.A., and Tontonoz, P. (2020). Therapeutic IDOL reduction ameliorates amyloidosis and improves cognitive function in APP/PS1 mice. Mol. Cell. Biol. 40:e518-19. (PMID 31964754)
• Wang, X., Cai, B., Yang, X., Sonubi, O.O., Zheng, Z., Ramakrishnan, R., Shi, H., Valenti, L., Pajvani, U.B., Sandhu, J., Infante, R.E., Radhakrishnan, A., Covey, D.F., Guan, K.L., Buck, J., Levin, L.R., Tontonoz, P., Schwabe, R.F., and Tabas, I. (2020). Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis. Cell Metabolism. Apr 1. pii: S1550-4131 (PMID 32259482)
• Priest, C. and Tontonoz, P. (2019). Inter-organ crosstalk in the metabolic syndrome. Nature Metabolism 1: 1177-1188. (PMID 32694672)
• Rajbhandari Prashant, Arneson Douglas, Hart Sydney K, Ahn In Sook, Diamante Graciel, Santos Luis C, Zaghari Nima, Feng An-Chieh, Thomas Brandon J, Vergnes Laurent, Lee Stephen D, Rajbhandari Abha K, Reue Karen, Smale Stephen T, Yang Xia, Tontonoz Peter   Single cell analysis reveals immune cell-adipocyte crosstalk regulating the transcription of thermogenic adipocytes eLife, 2019; 8: e49501.

• Stephen D Lee, Christina Priest, Mikael Bjursell, Jie Gao, Douglas V Arneson, In Sook Ahn, Graciel Diamante, J Edward van Veen, Megan G Massa, Anna C Calkin, Jason Kim, Harriet Andersén, Prashant Rajbhandari, Michelle Porritt, Alba Carreras, Andrea Ahnmark, Frank Seeliger, Ingela Maxvall, Pernilla Eliasson, Magnus Althage, Peter Åkerblad, Daniel Lindén, Tracy A Cole, Richard Lee, Helen Boyd, Mohammad Bohlooly-Y, Stephanie M Correa, Xia Yang, Peter Tontonoz, Cynthia Hong   IDOL regulates systemic energy balance through control of neuronal VLDLR expression, Nature Metabolism, 2019; 1(11): 1089-1100.

• Ramón-Vázquez Ana, de la Rosa Juan Vladimir, Tabraue Carlos, Lopez Felix, Díaz-Chico Bonifacio Nicolas, Bosca Lisardo, Tontonoz Peter, Alemany Susana, Castrillo Antonio   Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages Molecular and Cellular Biology, 2019; 39(5): e00376.

• Zhang Peixiang, Csaki Lauren S, Ronquillo Emilio, Baufeld Lynn J, Lin Jason Y, Gutierrez Alexis, Dwyer Jennifer R, Brindley David N, Fong Loren G, Tontonoz Peter, Young Stephen G, Reue Karen   Lipin 2/3 phosphatidic acid phosphatases maintain phospholipid homeostasis to regulate chylomicron synthesis The Journal of clinical investigation, 2019; 129(1): 281-295.

• Pearson Stephanie, Loft Anne, Rajbhandari Prashant, Simcox Judith, Lee Sanghoon, Tontonoz Peter, Mandrup Susanne, Villanueva Claudio J   Loss of TLE3 promotes the mitochondrial program in beige adipocytes and improves glucose metabolism Genes & development, 2019; 33(13-14): 747-762.

• Sandhu Jaspreet, Li Shiqian, Fairall Louise, Pfisterer Simon G, Gurnett Jennifer E, Xiao Xu, Weston Thomas A, Vashi Dipti, Ferrari Alessandra, Orozco Jose L, Hartman Celine L, Strugatsky David, Lee Stephen D, He Cuiwen, Hong Cynthia, Jiang Haibo, Bentolila Laurent A, Gatta Alberto T, Levine Tim P, Ferng Annie, Lee Richard, Ford David A, Young Stephen G, Ikonen Elina, Schwabe John W R, Tontonoz Peter.   Aster Proteins Facilitate Nonvesicular Plasma Membrane to ER Cholesterol Transport in Mammalian Cells. Cell, 2018; 175(2): 514-529.e20

• Wang Bo, Rong Xin, Palladino Elisa N D, Wang Jiafang, Fogelman Alan M, Martín Martín G, Alrefai Waddah A, Ford David A, Tontonoz Peter.   Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis. Cell Stem Cell, 2018; 22(2): 206-220.e4.

• Rajbhandari Prashant, Thomas Brandon J, Feng An-Chieh, Hong Cynthia, Wang Jiexin, Vergnes Laurent, Sallam Tamer, Wang Bo, Sandhu Jaspreet, Seldin Marcus M, Lusis Aldons J, Fong Loren G, Katz Melanie, Lee Richard, Young Stephen G, Reue Karen, Smale Stephen T, Tontonoz Peter IL-10 Signaling Remodels Adipose Chromatin Architecture to Limit Thermogenesis and Energy Expenditure. Cell. 2018; 172(1-2): 218-233.e17. 

• Gao J, Marosi M, Choi J, Achiro JM, Kim S, Li S Otis , Martin KC, Portera-Cailliau C, Tontonoz P The E3 ubiquitin ligase IDOL regulates synaptic ApoER2 levels and is important for plasticity and learning. eLife. 2017; 6: e29178. 

• Rong X, Wang B, Palladino EN, de Aguiar Vallim TQ, Ford DA, Tontonoz P ER phospholipid composition modulates lipogenesis during feeding and in obesity.The Journal of Clinical Investigation. 2017; 127: 3640-3651. 

• Zhang Li, Rajbhandari Prashant, Priest Christina, Sandhu Jaspreet, Wu Xiaohui, Temel Ryan, Castrillo Antonio, de Aguiar Vallim Thomas Q, Sallam Tamer, Tontonoz Peter Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP. eLife. 2017; 6: e28766. 

• Wang J, Rajbhandari P, Damianov A, Han A, Sallam T, Waki H, Villanueva CJ, Lee SD, Nielsen R, Mandrup S, Reue K, Young SG, Whitelegge J, Saez E, Black DL, Tontonoz P RNA-binding protein PSPC1 promotes the differentiation-dependent nuclear export of adipocyte RNAs. The Journal of Clinical Investigation. 2017; 127(3): 987-1004. 

• Beigneux AP, Miyashita K, Ploug M, Blom DJ, Ai M, Linton MF, Khovidhunkit W, Dufour R, Garg A, McMahon MA, Pullinger CR, Sandoval NP, Hu X, Allan CM, Larsson M, Machida T, Murakami M, Reue K, Tontonoz P, Goldberg IJ, Moulin P, Charrière S, Fong LG, Nakajima K, Young SG Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia. The New England Journal of Medicine. 2017; 376(17): 1647-1658. 

• Tontonoz P, Wu X Jones M, Zhang Z, Salisbury D, Sallam T Long Noncoding RNA Facilitated Gene Therapy Reduces Atherosclerosis in a Murine Model of Familial Hypercholesterolemia. Circulation. 2017; 136(8): 776-778. 

• Sallam T, Jones MC, Gilliland T, Zhang L, Wu X, Eskin A, Sandhu J, Casero D, Vallim TQ, Hong C, Katz M, Lee R, Whitelegge J, Tontonoz P Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis. Nature. 2016; 534(7605): 124-8. 

• Ito, A., Hong, C., Oka, K., Salazar, J.V., Diehl, C., Witztum, J.L., Diaz, M., Castrillo, A., Bensinger, S.V., Chan, L., and Tontonoz, P. Cholesterol accumulation in CD11c+ immune cells is a causal and targetable factor in autoimmune disease. Immunity. 2016; 45: 1311-1326. 

• Wang B, Rong X, Duerr MA, Hermanson DJ, Hedde PN, Wong JS, Vallim TQ, Cravatt BF, Gratton E, Ford DA, Tontonoz P Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet. Cell Metabolism. 2016; 23(3): 492-504. 

• Song NJ, Choi S, Rajbhandari P, Chang S-H, Kim S, Vergnes L, Kwon S-M, Yoon J-H, Lee S, Ku J-M, Lee J-S, Reue K, Koo S-H, Tontonoz P Park KW Prdm4 induction by the small molecule butein promotes white adipose tissue browning. Nature Chemical Biology. 2016; 12(7): 479-81.

• Tian Xiao Yu, Ganeshan Kirthana, Hong Cynthia, Nguyen Khoa D, Qiu Yifu, Kim Jason, Tangirala Rajendra K, Tontonoz Peter, Tonotonoz Peter, Chawla Ajay Thermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance. Cell metabolism. 2016; 23(1): 165-78. 

• Villa Genaro R, Hulce Jonathan J, Zanca Ciro, Bi Junfeng, Ikegami Shiro, Cahill Gabrielle L, Gu Yuchao, Lum Kenneth M, Masui Kenta, Yang Huijun, Rong Xin, Hong Cynthia, Turner Kristen M, Liu Feng, Hon Gary C, Jenkins David, Martini Michael, Armando Aaron M, Quehenberger Oswald, Cloughesy Timothy F, Furnari Frank B, Cavenee Webster K, Tontonoz Peter, Gahman Timothy C, Shiau Andrew K, Cravatt Benjamin F, Mischel Paul S An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers. Cancer cell. 2016; 30(5): 683-693.

• Parks Brian W, Sallam Tamer, Mehrabian Margarete, Psychogios Nikolas, Hui Simon T, Norheim Frode, Castellani Lawrence W, Rau Christoph D, Pan Calvin, Phun Jennifer, Zhou Zhenqi, Yang Wen-Pin, Neuhaus Isaac, Gargalovic Peter S, Kirchgessner Todd G, Graham Mark, Lee Richard, Tontonoz Peter, Gerszten Robert E, Hevener Andrea L, Lusis Aldons J Genetic architecture of insulin resistance in the mouse. Cell metabolism. 2015; 21(2): 334-46. 

• Ito Ayaka, Hong Cynthia, Rong Xin, Zhu Xuewei, Tarling Elizabeth J, Hedde Per Niklas, Gratton Enrico, Parks John, Tontonoz Peter LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. eLife. 2015; 4(1): e08009. 

• Rong, X., Wang, B., Dunham, M., Wong, J., Young, S.G., Gratton, E., Ford, D.A., and Tontonoz, P. Lpcat3-dependent production of arachidonyl phospholipids is a key determinant of triglyceride secretion. eLife. 2015; 4: e06557. 

• Choi J, Gao J, Kim J, Hong C, Kim J, Tontonoz P The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis.Science Translational Medicine. 2015; 7(314): 314ra184. 

• Tontonoz Peter, Cortez-Toledo Omar, Wroblewski Kevin, Hong Cynthia, Lim Laura, Carranza Rogelio, Conneely Orla, Metzger Daniel, Chao Lily C The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice. Molecular and cellular biology. 2015; 35(7): 1125-38. 

• Tontonoz Peter 2014 American Society for Clinical Investigation Presidential Address. Leading by example: pastors, mentors, physician-scientists, and the ASCI. The Journal of Clinical Investigation. 2014; 124(7): 2816-21. 

• Hong Cynthia, Tontonoz Peter Liver X receptors in lipid metabolism: opportunities for drug discovery. Nature Reviews. Drug Discovery. 2014; 13(6): 433-44. 

• Tessem, J.S., Moss, L.G., Chao, L.C., Lu, D., Tontonoz, P., Hohmeier, H.E., and Newgard, C.B. Nkx6.1 regulates islet β cell proliferation via Nr4a1 and Nr4a3 nuclear receptors. . Proc. Natl. Acad. Sci. USA. 2014; 111: 5242-5247. 

• Goddard, L.M., Murphy, T.J., Org, T., Enciso, J.M., Hashimoto-Partyka, M.K., Warren, C.M., Sanchez, L.A., Allen, N.C., Chao, L.C., Tontonoz, P., Mikkola, H., and Iruela-Arispe, M.L. Physiological vascular permeability requires induction of NR4A1 by progesterone receptor. Cell 2014; 156: 549-62. 

• Goulbourne, C.N., Gin, P., Tatar, A., Nobumori, C., Hoenger, A., Jiang, H., Grovenor, C.R.M., Esko, J.D., Goldberg, I.J., 5, Reue, K., Tontonoz, P., Bensadoun, A., Beigneux, A.P., Young, S.G., and Fong, L.G. The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries. . Cell Metabolism 2014; 19: 849-860. 

• Hong C, Marshall SM, McDaniel AL, Graham M, Layne JD, Cai L, Scotti E, Boyadjian R, Kim J, Chamberlain BT, Tangirala RK, Jung ME, Fong L, Lee R, Young SG, Temel RE, Tontonoz P The LXR-Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice. Cell Metabolism. 2014; 20(5): 910-8. 

• Sallam Tamer, Ito Ayaka, Rong Xin, Kim Jason, van Stijn Caroline, Chamberlain Brian T, Jung Michael E, Chao Lily C, Jones Marius, Gilliland Thomas, Wu XiaoHui, Su Grace L, Tangirala Rajendra K, Tontonoz Peter, Hong Cynthia The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis. Journal of lipid research. 2014; 55(6): 1120-30. 

• Calkin Anna C, Lee Stephen D, Kim Jason, Van Stijn Caroline M W, Wu Xiao-Hui, Lusis Aldons J, Hong Cynthia, Tangirala Rajendra I, Tontonoz Peter Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice. Circulation Research. 2014; 115(4): 442-9. 

• Villanueva Claudio J, Vergnes Laurent, Wang Jiexin, Drew Brian G, Hong Cynthia, Tu Yiping, Hu Yan, Peng Xu, Xu Feng, Saez Enrique, Wroblewski Kevin, Hevener Andrea L, Reue Karen, Fong Loren G, Young Stephen G, Tontonoz Peter Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs. Cell Metabolism. 2013; 17(3): 423-35. 

• Chao Lily C, Soto Erin, Hong Cynthia, Ito Ayaka, Pei Liming, Chawla Ajay, Conneely Orla M, Tangirala Rajendra K, Evans Ronald M, Tontonoz Peter Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice. Journal of Lipid Research. 2013; 54(3): 806-15. 

• Zhang Li, Xu Ming, Scotti Elena, Chen Zhijian J, Tontonoz Peter Both K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor.Journal of Lipid Research. 2013; 54(5): 1410-20. 

• Scotti Elena, Calamai Martino, Goulbourne Chris N, Zhang Li, Hong Cynthia, Lin Ron R, Choi Jinkuk, Pilch Paul F, Fong Loren G, Zou Peng, Ting Alice Y, Pavone Francesco S, Young Stephen G, Tontonoz Peter IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor. Molecular and Cellular Biology. 2013; 33(8): 1503-14. 

• Rong, X., Albert, C.J., Hong, C., Chamberlain, B., Tarling, E.J., Ito, A., Gao, J., Edwards, P.A., Jung, M., Ford, D.A., and Tontonoz, P. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell Metabolism 2013; 18: 685-697. 
• Beaven, S.W., Matveyenko, A., Wroblewski, K., Chao, L.C, Wilpitz, D., Hsu, T.W., Lentz, J., Drew, B., Hevener, A., and Tontonoz, P. Reciprocal regulation of hepatic and adipose lipogenesis by LXRs in obesity and insulin resistance. Cell Metabolism 2013; 18: 106-117. 

• Halperin Daniel S, Pan Calvin, Lusis Aldons J, Tontonoz Peter Vestigial-like 3 is an inhibitor of adipocyte differentiation. Journal of Lipid Research. 2013; 54(2): 473-81. 
• Hong Cynthia, Kidani Yoko, A-Gonzalez Noelia, Phung Tram, Ito Ayaka, Rong Xin, Ericson Katrin, Mikkola Hanna, Beaven Simon W, Miller Lloyd S, Shao Wen-Hai, Cohen Philip L, Castrillo Antonio, Tontonoz Peter, Bensinger Steven J Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. The Journal of Clinical Investigation. 2012; 122(1): 337-47. 
• Zhang Li, Reue Karen, Fong Loren G, Young Stephen G, Tontonoz Peter Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.Arteriosclerosis, Thrombosis, and Vascular Biology. 2012; 32(11): 2541-6. 
• Hong Cynthia, Bradley Michele N, Rong Xin, Wang Xuping, Wagner Alan, Grijalva Victor, Castellani Lawrence W, Salazar Jon, Realegeno Susan, Boyadjian Rima, Fogelman Alan M, Van Lenten Brian J, Reddy Srinivasa T, Lusis Aldons J, Tangirala Rajendra K, Tontonoz Peter LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice. Journal of Lipid Research. 2012; 53(6): 1126-33. 
• Chao Lily C, Wroblewski Kevin, Ilkayeva Olga R, Stevens Robert D, Bain James, Meyer Gretchen A, Schenk Simon, Martinez Leonel, Vergnes Laurent, Narkar Vihang A, Drew Brian G, Hong Cynthia, Boyadjian Rima, Hevener Andrea L, Evans Ronald M, Reue Karen, Spencer Melissa J, Newgard Christopher B, Tontonoz Peter Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization. Journal of Lipid Research. 2012; 53(12): 2610-9. 
• Chen Xuqi, McClusky Rebecca, Chen Jenny, Beaven Simon W, Tontonoz Peter, Arnold Arthur P, Reue Karen The number of x chromosomes causes sex differences in adiposity in mice. PLoS genetics. 2012; 8(5): e1002709. 
• Calkin Anna C, Tontonoz Peter Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nature Reviews. Molecular Cell Biology. 2012; 13(4): 213-24. 
• Guo Deliang, Reinitz Felicia, Youssef Mary, Hong Cynthia, Nathanson David, Akhavan David, Kuga Daisuke, Amzajerdi Ali Nael, Soto Horacio, Zhu Shaojun, Babic Ivan, Tanaka Kazuhiro, Dang Julie, Iwanami Akio, Gini Beatrice, Dejesus Jason, Lisiero Dominique D, Huang Tiffany T, Prins Robert M, Wen Patrick Y, Robins H Ian, Prados Michael D, Deangelis Lisa M, Mellinghoff Ingo K, Mehta Minesh P, James C David, Chakravarti Arnab, Cloughesy Timothy F, Tontonoz Peter, Mischel Paul S An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discovery. 2011; 1(5): 442-56. 
• Hong Cynthia, Walczak Robert, Dhamko Helena, Bradley Michelle N, Marathe Chaitra, Boyadjian Rima, Salazar Jon V, Tontonoz Peter Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. Journal of Lipid Research. 2011; 52(3): 531-9. 
• Calkin Anna C, Goult Benjamin T, Zhang Li, Fairall Louise, Hong Cynthia, Schwabe John W R, Tontonoz Peter FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(50): 20107-12. 
• Beaven, S.W., Wroblewski, K., Wang, J., Bensinger, S.J., Tsukamoto, H. and Tontonoz, P. LXR signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. . Gastroenterology 2011; 140: 1052-62. 
• Beaven Simon W, Wroblewski Kevin, Wang Jiaohong, Hong Cynthia, Bensinger Steven, Tsukamoto Hide, Tontonoz Peter Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease. Gastroenterology. 2011; 140(3): 1052-62. 
• Villanueva Claudio J, Waki Hironori, Godio Cristina, Nielsen Ronni, Chou Wen-Ling, Vargas Leo, Wroblewski Kevin, Schmedt Christian, Chao Lily C, Boyadjian Rima, Mandrup Susanne, Hevener Andrea, Saez Enrique, Tontonoz Peter TLE3 is a dual-function transcriptional coregulator of adipogenesis. Cell Metabolism. 2011; 13(4): 413-27. 
• Scotti Elena, Hong Cynthia, Yoshinaga Yuko, Tu Yiping, Hu Yan, Zelcer Noam, Boyadjian Rima, de Jong Pieter J, Young Stephen G, Fong Loren G, Tontonoz Peter Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists. Molecular and Cellular Biology. 2011; 31(9): 1885-93. 
• Zhang Li, Fairall Louise, Goult Benjamin T, Calkin Anna C, Hong Cynthia, Millard Christopher J, Tontonoz Peter, Schwabe John W R The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. Genes & Development. 2011; 25(12): 1262-74. 
• Weissglas-Volkov Daphna, Calkin Anna C, Tusie-Luna Teresa, Sinsheimer Janet S, Zelcer Noam, Riba Laura, Tino Ana Maria Vargas, Ordoñez-Sánchez Maria Luisa, Cruz-Bautista Ivette, Aguilar-Salinas Carlos A, Tontonoz Peter, Pajukanta Päivi The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans. The Journal of Clinical Investigation. 2011; 121(8): 3062-71. 
• Feig Jonathan E, Pineda-Torra Ines, Sanson Marie, Bradley Michelle N, Vengrenyuk Yuliya, Bogunovic Dusan, Gautier Emmanuel L, Rubinstein Daniel, Hong Cynthia, Liu Jianhua, Wu Chaowei, van Rooijen Nico, Bhardwaj Nina, Garabedian Michael, Tontonoz Peter, Fisher Edward A LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. The Journal of Clinical Investigation. 2010; 120(12): 4415-24. 
• Calkin Anna C, Tontonoz Peter Liver x receptor signaling pathways and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2010; 30(8): 1513-8. 
• Hong Cynthia, Duit Sarah, Jalonen Pilvi, Out Ruud, Scheer Lilith, Sorrentino Vincenzo, Boyadjian Rima, Rodenburg Kees W, Foley Edan, Korhonen Laura, Lindholm Dan, Nimpf Johannes, van Berkel Theo J C, Tontonoz Peter, Zelcer Noam The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. The Journal of Biological Chemistry. 2010; 285(26): 19720-6. 
• Park Kye Won, Waki Hironori, Choi Sung-Pil, Park Ki-Moon, Tontonoz Peter The small molecule phenamil is a modulator of adipocyte differentiation and PPARgamma expression. Journal of lipid research. 2010; 51(9): 2775-84. 
• Bensinger Steven J, Tontonoz Peter A Nurr1 pathway for neuroprotection. Cell. 2009; 137(1): 26-8. 
• A-Gonzalez Noelia, Bensinger Steven J, Hong Cynthia, Beceiro Susana, Bradley Michelle N, Zelcer Noam, Deniz Jose, Ramirez Cristina, Díaz Mercedes, Gallardo German, de Galarreta Carlos Ruiz, Salazar Jon, Lopez Felix, Edwards Peter, Parks John, Andujar Miguel, Tontonoz Peter, Castrillo Antonio Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity. 2009; 31(2): 245-58. 
• Chao Lily C, Wroblewski Kevin, Zhang Zidong, Pei Liming, Vergnes Laurent, Ilkayeva Olga R, Ding Shi Ying, Reue Karen, Watt Matthew J, Newgard Christopher B, Pilch Paul F, Hevener Andrea L, Tontonoz Peter Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes. 2009; 58(12): 2788-96. 
• Zelcer Noam, Hong Cynthia, Boyadjian Rima, Tontonoz Peter LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.Science (New York, N.Y.). 2009; 325(5936): 100-4. 
• Marathe Chaitra, Bradley Michelle N, Hong Cynthia, Chao Lily, Wilpitz Damien, Salazar Jon, Tontonoz Peter Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARgamma-/-, PPARdelta-/-, PPARgammadelta-/-, or LXRalphabeta-/- bone marrow. Journal of lipid research. 2009; 50(2): 214-24. 
• Dean Jason T, Tran Linh, Beaven Simon, Tontonoz Peter, Reue Karen, Dipple Katrina M, Liao James C Resistance to diet-induced obesity in mice with synthetic glyoxylate shunt. Cell metabolism. 2009; 9(6): 525-36. 
• Hsu Jeffrey J, Lu Jinxiu, Huang Michael S, Geng Yifan, Sage Andrew P, Bradley Michelle N, Tontonoz Peter, Demer Linda L, Tintut Yin T0901317, an LXR agonist, augments PKA-induced vascular cell calcification. FEBS letters. 2009; 583(8): 1344-8. 
• Park Kye Won, Waki Hironori, Kim Woo-Kyun, Davies Brandon S J, Young Stephen G, Parhami Farhad, Tontonoz Peter The small molecule phenamil induces osteoblast differentiation and mineralization. Molecular and cellular biology. 2009; 29(14): 3905-14. 
• Hummasti Sarah, Tontonoz Peter Adopting new orphans into the family of metabolic regulators. Molecular endocrinology (Baltimore, Md.). 2008; 22(8): 1743-53. 
• Jiang Qingguang, Lee C Y Daniel, Mandrekar Shweta, Wilkinson Brandy, Cramer Paige, Zelcer Noam, Mann Karen, Lamb Bruce, Willson Timothy M, Collins Jon L, Richardson Jill C, Smith Jonathan D, Comery Thomas A, Riddell David, Holtzman David M, Tontonoz Peter, Landreth Gary E ApoE promotes the proteolytic degradation of Abeta. Neuron. 2008; 58(5): 681-93. 
• Gallardo-Soler Alejandro, Gómez-Nieto Carlos, Campo María Luisa, Marathe Chaitra, Tontonoz Peter, Castrillo Antonio, Corraliza Inés Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity.Molecular endocrinology (Baltimore, Md.). 2008; 22(6): 1394-402. 
• Park Kye Won, Halperin Daniel S, Tontonoz Peter Before they were fat: adipocyte progenitors. Cell metabolism. 2008; 8(6): 454-7. 
• Tontonoz, P. and Spiegelman, B.M. Beyond fat: the diverse biology of PPARgamma. Ann Rev Biochem 2008; 77: 289-312. 
• Hong Cynthia, Tontonoz Peter Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Current opinion in genetics & development. 2008; 18(5): 461-7. 
• Tontonoz Peter, Spiegelman Bruce M Fat and beyond: the diverse biology of PPARgamma. Annual review of biochemistry. 2008; 77(6): 289-312. 
• Hummasti Sarah, Hong Cynthia, Bensinger Steven J, Tontonoz Peter HRASLS3 is a PPARgamma-selective target gene that promotes adipocyte differentiation. Journal of lipid research. 2008; 49(12): 2535-44. 
• Park, K.W., Waki, H., Villanueva, C.J., Monticelli, L., Hong, C., Kang, S., MacDougald, O.A., Goldrath, A.W., and Tontonoz, P. Id2 is a small molecule-inducible modulator of PPARgamma expression and adipocyte differentiation. Molecular Endocrinology 2008; 22: 2038-2048. 
• Chao Lily C, Bensinger Steven J, Villanueva Claudio J, Wroblewski Kevin, Tontonoz Peter Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.Molecular endocrinology (Baltimore, Md.). 2008; 22(12): 2596-608. 
• Park Kye Won, Waki Hironori, Villanueva Claudio J, Monticelli Laurel A, Hong Cynthia, Kang Sona, MacDougald Ormond A, Goldrath Ananda W, Tontonoz Peter Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation. Molecular endocrinology (Baltimore, Md.). 2008; 22(9): 2038-48. 
• Bensinger Steven J, Tontonoz Peter Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008; 454(7203): 470-7. 
• Bensinger Steven J, Bradley Michelle N, Joseph Sean B, Zelcer Noam, Janssen Edith M, Hausner Mary Ann, Shih Roger, Parks John S, Edwards Peter A, Jamieson Beth D, Tontonoz Peter LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 2008; 134(1): 97-111. 
• Marathe C, Bradley MN, Hong C, Chao LC, Wilpitz D, Salazar J, and Tontonoz P. Preserved glucose tolerance in high fat diet fed C57BL/6 mice transplanted with PPARγ-/-, PPARδ-/-, PPARγδ-/- or LXRαβ-/- bone marrow. J. Lipid Res. 2008; 50: 214-224. 
• Naiki Yoshikazu, Sorrentino Rosalinda, Wong Michelle H, Michelsen Kathrin S, Shimada Kenichi, Chen Shuang, Yilmaz Atilla, Slepenkin Anatoly, Schröder Nicolas W J, Crother Timothy R, Bulut Yonca, Doherty Terence M, Bradley Michelle, Shaposhnik Zory, Peterson Ellena M, Tontonoz Peter, Shah Prediman K, Arditi Moshe TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.Journal of immunology (Baltimore, Md. : 1950). 2008; 181(10): 7176-85. 
• Davies Brandon S J, Waki Hironori, Beigneux Anne P, Farber Emily, Weinstein Michael M, Wilpitz Damien C, Tai Li-Jung, Evans Ronald M, Fong Loren G, Tontonoz Peter, Young Stephen G The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma. Molecular endocrinology (Baltimore, Md.). 2008; 22(11): 2496-504. 
• Zelcer Noam, Khanlou Negar, Clare Ryan, Jiang Qingguang, Reed-Geaghan Erin G, Landreth Gary E, Vinters Harry V, Tontonoz Peter Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(25): 10601-6. 
• Cao Fei, Castrillo Antonio, Tontonoz Peter, Re Fabio, Byrne Gerald I Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infection and immunity. 2007; 75(2): 753-9. 
• Waki Hironori, Tontonoz Peter Endocrine functions of adipose tissue. Annual review of pathology. 2007; 2(2): 31-56. 
• Bradley Michelle N, Hong Cynthia, Chen Mingyi, Joseph Sean B, Wilpitz Damien C, Wang Xuping, Lusis Aldons J, Collins Allan, Hseuh Willa A, Collins Jon L, Tangirala Rajendra K, Tontonoz Peter Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. The Journal of clinical investigation. 2007; 117(8): 2337-46. 
• Molteni Valentina, Li Xiaolin, Nabakka Juliet, Liang Fang, Wityak John, Koder Alan, Vargas Leo, Romeo Russell, Mitro Nico, Mak Puiying A, Seidel H Martin, Haslam Jennifer A, Chow Donald, Tuntland Tove, Spalding Tracy A, Brock Ansgar, Bradley Michelle, Castrillo Antonio, Tontonoz Peter, Saez Enrique N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta. Journal of medicinal chemistry. 2007; 50(17): 4255-9. 
• Chao Lily C, Zhang Zidong, Pei Liming, Saito Tsugumichi, Tontonoz Peter, Pilch Paul F Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Molecular endocrinology (Baltimore, Md.). 2007; 21(9): 2152-63. 
• Waki Hironori, Tontonoz Peter STAMPing out Inflammation. Cell. 2007; 129(3): 451-2. 
• Waki Hironori, Park Kye Won, Mitro Nico, Pei Liming, Damoiseaux Robert, Wilpitz Damien C, Reue Karen, Saez Enrique, Tontonoz Peter The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell metabolism. 2007; 5(5): 357-70. 
• Chow Edward K, Castrillo Antonio, Shahangian Arash, Pei Liming, O'Connell Ryan M, Modlin Robert L, Tontonoz Peter, Cheng Genhong A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. The Journal of experimental medicine. 2006; 203(12): 2589-602. 
• Chow, E.K., Castrillo, A., Shahangian, A., O'Connell, R.M., Pei, L., Tontonoz, P., and Cheng, G. Critical role of IRF3-dependent RXRa repression in hepatotoxicity associated with viral infections. J. Exp Med 2006; 203: 2589-2602. 
• Baldán Angel, Pei Liming, Lee Richard, Tarr Paul, Tangirala Rajendra K, Weinstein Michael M, Frank Joy, Li Andrew C, Tontonoz Peter, Edwards Peter A Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow. Arteriosclerosis, thrombosis, and vascular biology. 2006; 26(10): 2301-7. 
• Zelcer Noam, Tontonoz Peter Liver X receptors as integrators of metabolic and inflammatory signaling. The Journal of clinical investigation. 2006; 116(3): 607-14. 
• Pei Liming, Waki Hironori, Vaitheesvaran Bhavapriya, Wilpitz Damien C, Kurland Irwin J, Tontonoz Peter NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nature medicine. 2006; 12(9): 1048-55. 
• Beaven Simon W, Tontonoz Peter Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annual review of medicine. 2006; 57(3): 313-29. 
• Chen Mingyi, Bradley Michelle N, Beaven Simon W, Tontonoz Peter Phosphorylation of the liver X receptors. FEBS letters. 2006; 580(20): 4835-41. 
• Pei Liming, Castrillo Antonio, Tontonoz Peter Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Molecular endocrinology (Baltimore, Md.). 2006; 20(4): 786-94. 
• Hummasti S and Tontonoz P The PPAR N-terminal domain controls isotype-selective gene expression and adipogenesis. Molecular Endocrinology 2006; 20: 1261-1275. 
• Marathe Chaitra, Bradley Michelle N, Hong Cynthia, Lopez Felix, Ruiz de Galarreta Carlos M, Tontonoz Peter, Castrillo Antonio The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. The Journal of biological chemistry. 2006; 281(43): 32197-206. 
• Hummasti Sarah, Tontonoz Peter The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis. Molecular endocrinology (Baltimore, Md.). 2006; 20(6): 1261-75. 
• Arai Satoko, Shelton John M, Chen Mingyi, Bradley Michelle N, Castrillo Antonio, Bookout Angie L, Mak Puiying A, Edwards Peter A, Mangelsdorf David J, Tontonoz Peter, Miyazaki Toru A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell metabolism. 2005; 1(3): 201-13.
• Lin Jiandie, Yang Ruojing, Tarr Paul T, Wu Pei-Hsuan, Handschin Christoph, Li Siming, Yang Wenli, Pei Liming, Uldry Marc, Tontonoz Peter, Newgard Christopher B, Spiegelman Bruce M Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell. 2005; 120(2): 261-73. 
• Chen Mingyi, Beaven Simon, Tontonoz Peter Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha.Journal of lipid research. 2005; 46(12): 2570-9. 
• Pei Liming, Castrillo Antonio, Chen Mingyi, Hoffmann Alexander, Tontonoz Peter Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. The Journal of biological chemistry. 2005; 280(32): 29256-62. 
• Bradley Michelle N, Tontonoz Peter Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists. Arteriosclerosis, thrombosis, and vascular biology. 2005; 25(1): 10-1. 
• Zelcer Noam, Tontonoz Peter SUMOylation and PPARgamma: wrestling with inflammatory signaling. Cell metabolism. 2005; 2(5): 273-5. 
• Sheth Sonal S, Castellani Lawrence W, Chari Soumya, Wagg Cory, Thipphavong Christopher K, Bodnar Jackie S, Tontonoz Peter, Attie Alan D, Lopaschuk Gary D, Lusis Aldons J Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition. Journal of lipid research. 2005; 46(1): 123-34. 
• Pei Liming, Tontonoz Peter Fat's loss is bone's gain. The Journal of clinical investigation. 2004; 113(6): 805-6. 
• Joseph Sean B, Bradley Michelle N, Castrillo Antonio, Bruhn Kevin W, Mak Puiying A, Pei Liming, Hogenesch John, O'connell Ryan M, Cheng Genhong, Saez Enrique, Miller Jeffery F, Tontonoz Peter LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell. 2004; 119(2): 299-309. 
• Hummasti Sarah, Laffitte Bryan A, Watson Michael A, Galardi Cristin, Chao Lily C, Ramamurthy Lakshman, Moore John T, Tontonoz Peter Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. Journal of lipid research. 2004; 45(4): 616-25. 
• Castrillo Antonio, Tontonoz Peter Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annual review of cell and developmental biology. 2004; 20(6): 455-80. 
• Castrillo Antonio, Tontonoz Peter PPARs in atherosclerosis: the clot thickens. The Journal of clinical investigation. 2004; 114(11): 1538-40. 
• Walczak Robert, Joseph Sean B, Laffitte Bryan A, Castrillo Antonio, Pei Liming, Tontonoz Peter Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors. The Journal of biological chemistry. 2004; 279(11): 9905-11. 
• Laffitte Bryan A, Chao Lily C, Li Jing, Walczak Robert, Hummasti Sarah, Joseph Sean B, Castrillo Antonio, Wilpitz Damien C, Mangelsdorf David J, Collins Jon L, Saez Enrique, Tontonoz Peter Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(9): 5419-24. 
• Castrillo Antonio, Joseph Sean B, Vaidya Sagar A, Haberland Margaret, Fogelman Alan M, Cheng Genhong, Tontonoz Peter Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Molecular cell. 2003; 12(4): 805-16. 
• Joseph Sean B, Tontonoz Peter LXRs: new therapeutic targets in atherosclerosis?. Current opinion in pharmacology. 2003; 3(2): 192-7. 
• Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ and Tontonoz P Liver X receptor dependent inhibition of MMP-9 gene expression in macrophages. J. Biol. Chem 2003; 278: 10443-10449. 
• Tontonoz Peter, Mangelsdorf David J Liver X receptor signaling pathways in cardiovascular disease. Molecular endocrinology (Baltimore, Md.). 2003; 17(6): 985-93. 
• Castrillo Antonio, Joseph Sean B, Marathe Chaitra, Mangelsdorf David J, Tontonoz Peter Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. The Journal of biological chemistry. 2003; 278(12): 10443-9. 
• Joseph Sean B, Castrillo Antonio, Laffitte Bryan A, Mangelsdorf David J, Tontonoz Peter Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature medicine. 2003; 9(2): 213-9. 
• Walczak Robert, Tontonoz Peter Setting fat on fire. Nature medicine. 2003; 9(11): 1348-9. 
• Laffitte Bryan A, Joseph Sean B, Chen Mingyi, Castrillo Antonio, Repa Joyce, Wilpitz Damien, Mangelsdorf David, Tontonoz Peter The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Molecular and cellular biology. 2003; 23(6): 2182-91. 
• Joseph Sean B, Laffitte Bryan A, Patel Parthive H, Watson Michael A, Matsukuma Karen E, Walczak Robert, Collins Jon L, Osborne Timothy F, Tontonoz Peter Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. The Journal of biological chemistry. 2002; 277(13): 11019-25. 
• Tangirala Rajendra K, Bischoff Eric D, Joseph Sean B, Wagner Brandee L, Walczak Robert, Laffitte Bryan A, Daige Chris L, Thomas Diane, Heyman Richard A, Mangelsdorf David J, Wang Xuping, Lusis Aldons J, Tontonoz Peter, Schulman Ira G Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99(18): 11896-901. 
• Laffitte Bryan A, Tontonoz Peter Orphan nuclear receptors find a home in the arterial wall. Current atherosclerosis reports. 2002; 4(3): 213-21. 
• Walczak Robert, Tontonoz Peter PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. Journal of lipid research. 2002; 43(2): 177-86. 
• Xu Jun, Xiao Gary, Trujillo Chuck, Chang Vicky, Blanco Lilia, Joseph Sean B, Bassilian Sara, Saad Mohammed F, Tontonoz Peter, Lee W N Paul, Kurland Irwin J Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. The Journal of biological chemistry. 2002; 277(52): 50237-44. 
• Mak Puiying A, Laffitte Bryan A, Desrumaux Catherine, Joseph Sean B, Curtiss Linda K, Mangelsdorf David J, Tontonoz Peter, Edwards Peter A Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta.The Journal of biological chemistry. 2002; 277(35): 31900-8. 
• Kast Heidi R, Goodwin Bryan, Tarr Paul T, Jones Stacey A, Anisfeld Andrew M, Stoltz Catherine M, Tontonoz Peter, Kliewer Steve, Willson Timothy M, Edwards Peter A Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. The Journal of biological chemistry. 2002; 277(4): 2908-15. 
• Joseph Sean B, McKilligin Elaine, Pei Liming, Watson Michael A, Collins Alan R, Laffitte Bryan A, Chen Mingyi, Noh Grace, Goodman Joanne, Hagger Graham N, Tran Jonathan, Tippin Tim K, Wang Xuping, Lusis Aldons J, Hsueh Willa A, Law Ronald E, Collins Jon L, Willson Timothy M, Tontonoz Peter Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99(11): 7604-9. 
• Chawla A, Boisvert WA, Lee C, Laffitte BA, Barak Y, Joseph SB, Nagy L, Liao D, Edwards PA, Curtiss LK, Evans RM and Tontonoz P A PPARg-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular Cell 2001; 7: 161-171. 
• Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL and Tontonoz P Autoregulation of the human LXRa promoter. Mol. Cell. Biol 2001; 21: 7558-7568. 
• Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, Tontonoz P LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(2): 507-12. 
• Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P and Evans RM PPARg dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation. Nature Medicine 2001; 7: 48-52. 
• Ahuja HS, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P and Davies P Tissue-specific effects of RXR and PPARg ligands on metabolic gene expression in diabetic rodents. Mol. Pharmacol 2001; 59: 765-773. 
• Venkateswaren A, Laffitte B, Joseph S, Mak A, Edwards PA and Tontonoz P Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRa. Proc. Natl. Acad. Sci. U.S.A 2000; 97: 12097-12102. 
• Lee, H., Shi, W., Tontonoz, P., Wang, S., Evans, R.M., Berliner, J.A., and Nagy, L. Oxidized phospholipids activate PPARa and induce endothelial synthesis of monocyte activators. Circulation Research 2000; 87: 516-521. 
• Tontonoz P and Nagy L Regulation of macrophage gene expression by PPARg: implications for cardiovascular disease. Curr. Opin. Lipidol. 1999; 10: 485-490.
• Saez E, Tontonoz P, Nelson M, Alvarez JGA, Baird SM, Thomazy V and Evans RM Activators of the nuclear receptor PPARg promote colonic polyp formation in the MIN mouse. Nature Medicine 1998; 4: 1058-1061. 
• Nagy L, Tontonoz P, Alvarez JGA, Chen H and Evans RM Oxidized LDL regulates macrophage gene expression through ligand activation of PPARg. Cell 1998; 93: 229-240. 
• Tontonoz P, Nagy L, Alvarez JGA, Thomazy V and Evans RM PPARg promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241-252. 
• Devine JH, Eubank DW, Clouthier DE, Tontonoz P, Spiegelman BM, Hammer RE and Beale EG Adipose expression of the phosphoenol-pyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis- retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J. Biol. Chem 1997; 274: 13604-13612. 
• Hollenberg AN, Susulic VS, Madura JP, Zhang B, Moller DE, Tontonoz P, Sarraf P, Spiegelman BM and Lowell BB Functional antagonism between C/EBPa and PPARg on the leptin promoter. J. Biol. Chem. 1997; 272: 5283-5290. 
• Mueller E, Saraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher CDM, Singer S and Spiegelman BM Terminal differentiation of human breast cancer through PPARg. Molecular Cell 1997; 1: 465-470. 
• Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CDM, Brun RP, Mueller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator activated receptor g- and the retinoid X receptor. Proc. Natl. Acad. Sci. U.S.A 1997; 94: 237-241. 
• Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM Differential activation of adipogenesis by multiple PPAR isoforms. Genes & Development. . 1996; 10(8): 974-84. 
• Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM and Evans RM 15-deoxy-D12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARg. Cell 1995; 83: 803-812. 
• Tontonoz P, Hu E, Devine J, Beale EG and Spiegelman BM PPARg2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol 1995; 15: 351-357. 
• Hu E, Tontonoz P and Spiegelman BM Transdifferentiation of myoblasts by the adipogenic transcription factors PPARg and C/EBPa. Proc. Natl. Acad. Sci. U.S.A 1995; 92: 9856-9860. 
• Tontonoz P, Hu E and Spiegelman BM Stimulation of adipogenesis in fibroblasts by PPARg2, a lipid-activated transcription factor. Cell 1994; 79: 1147-1156. 
• Tontonoz P, Hu E, Graves RA, Budavari A, Spiegelman B mPPARg2:tissue-specific regulator of an adipocyte enhancer. Genes & Development 1994; 8: 1224-1234. 
• Tontonoz P, Kim JB, Graves RA, Spiegelman BM ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Molecular and cellular biology. . 1993; 13(8): 4753-9. 
• Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. The Journal of biological chemistry . 1993; 268(10): 6823-6. 
• Graves RA, Tontonoz P, Spiegelman BM Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression. Molecular and cellular biology. . 1992; 12(3): 1202-8. 
• Graves RA, Tontonoz P, Ross SR, Spiegelman BM Identification of a potent adipocyte-specific enhancer: involvement of an NF-1-like factor. Genes & Development. . 1991; 5(3): 428-37.